ENDECE

https://endece.com/ndc-1308-a-novel-therapeutic-for-acute-respiratory-distress-syndrome-ards-including-covid-19-patients/

As SARS-Cov-2 / COVID-19 continues to dominate our lives, the world is looking for a way to get back to “Normal”. Unfortunately, “Normal”, is a long ways off and may have to be redefined in general. ENDECE is excited about the promise of NDC-1308 for the treatment of Acute Respiratory Distress Syndrome (ARDS) and specifically as a much needed treatment of ARDS in COVID-19 patients.

NDC-1308 a novel therapeutic for Acute Respiratory Distress Syndrome (ARDS) including COVID-19 patients NDC-1308 is a novel therapeutic for Acute Respiratory Distress Syndrome (ARDS) including SARS-CoV-2 and COVID-19 patients